LivaNova PLC (LIVN) vs Neogen Corporation (NEOG)
LivaNova PLC and Neogen Corporation are both Medical Devices companies. LivaNova PLC is the larger, with a market value of $4.2B against $3.0B — 1.4× the size. Neogen Corporation has negative trailing earnings, so its P/E is not meaningful; LivaNova PLC trades at 22.2×. LivaNova PLC grew revenue faster over the last twelve months: 12.4% against −2.72%. LivaNova PLC has the higher net margin (12.8% vs −0.91%) and the higher return on invested capital (10.6% vs −0.50%). Across the 20 metrics below, LivaNova PLC leads on 16 and Neogen Corporation on 4.
Valuation
Profitability
| Metric | LIVN | NEOG | Medical Devices median |
|---|---|---|---|
| Gross margin | 68.10% | 46.93% | 56.01% |
| Operating margin | 12.74% | (2.48%) | (15.03%) |
| Net margin | 12.81% | (0.91%) | (20.40%) |
| Free cash flow margin | 10.57% | 3.68% | (7.24%) |
| Return on equity | 15.40% | (0.38%) | (15.32%) |
| Return on assets | 7.33% | (0.23%) | (19.72%) |
| Return on invested capital | 10.63% | (0.50%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack